Adipogenesis regulatory factor (ADIRF,), also known as C10orf116 or APM2, was underexpressed in gastric cancer and manifested a significant relationship with higher pathological stage, higher clinical stage, lymph node metastasis, and poorer distant relapse-free survival [24]. This evidence concerns the gene ADIRF and metastatic malignant neoplasm in the lymph nodes.